• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[骨转换的生化标志物。新观点。类风湿关节炎骨代谢标志物的治疗]

[Biochemical markers of bone turnover. New aspect. Therapy of rheumatoid arthritis for bone metabolic marker].

作者信息

Okada Yosuke, Nawata Masao, Tanaka Yoshiya

机构信息

The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health.

出版信息

Clin Calcium. 2009 Aug;19(8):1186-90.

PMID:19638703
Abstract

Rheumatoid arthritis (RA) is characterized by inflammatory synovitis, erosive arthritis and joint destruction. Recent evidence indicates that inflammatory cytokines such as TNF-alphaor IL-6 plays a pathological role in joint destruction and osteoporosis and that anti-cytokine therapy provides significant protection against the process. In this article, we described our findings that TNF-alphablocking therapy decreased urinary crosslinked N-telopeptide of type I collagen and increased serum bone alkaline phosphatase in RA patients.

摘要

类风湿关节炎(RA)的特征是炎症性滑膜炎、侵蚀性关节炎和关节破坏。最近的证据表明,诸如肿瘤坏死因子-α或白细胞介素-6等炎性细胞因子在关节破坏和骨质疏松中起病理作用,并且抗细胞因子疗法可对该过程提供显著保护。在本文中,我们描述了我们的研究发现,即肿瘤坏死因子-α阻断疗法可降低RA患者尿液中I型胶原交联N-端肽水平,并提高血清骨碱性磷酸酶水平。

相似文献

1
[Biochemical markers of bone turnover. New aspect. Therapy of rheumatoid arthritis for bone metabolic marker].[骨转换的生化标志物。新观点。类风湿关节炎骨代谢标志物的治疗]
Clin Calcium. 2009 Aug;19(8):1186-90.
2
The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis.英夫利昔单抗对类风湿关节炎患者骨代谢标志物的影响。
Rheumatology (Oxford). 2006 Jun;45(6):761-4. doi: 10.1093/rheumatology/kei280. Epub 2006 Jan 25.
3
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.英夫利昔单抗对类风湿关节炎患者骨和软骨转换标志物的长期影响。
Ann Rheum Dis. 2008 Mar;67(3):353-7. doi: 10.1136/ard.2007.076604. Epub 2007 Jul 20.
4
Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.类风湿关节炎和银屑病关节炎患者接受肿瘤坏死因子抑制剂治疗后近节指间关节周围骨量增加和骨转换标志物的变化。
J Rheumatol. 2013 May;40(5):653-62. doi: 10.3899/jrheum.120397. Epub 2013 Mar 1.
5
Requirement of methotrexate in combination with anti-tumor necrosis factor-alpha therapy for adequate suppression of osteoclastogenesis in rheumatoid arthritis.甲氨蝶呤联合抗肿瘤坏死因子-α疗法对类风湿关节炎中破骨细胞生成的充分抑制作用的需求。
J Rheumatol. 2007 Dec;34(12):2326-33. Epub 2007 Nov 15.
6
[Efficacy of anti-cytokines and anti-RANKL antibody for treatment of RA and osteoporosis].抗细胞因子和抗RANKL抗体治疗类风湿关节炎和骨质疏松症的疗效
Clin Calcium. 2007 Nov;17(11):1762-8.
7
[Changes in certain biochemical markers of bone turnover in rheumatoid arthritis patients treated with short-term low dose glucocorticosteroids].
Przegl Lek. 2005;62(12):1384-6.
8
[Rheumatoid arthritis and osteoporosis: trends in their treatments].[类风湿性关节炎与骨质疏松症:治疗趋势]
Nihon Rinsho. 2006 Dec;64(12):2359-66.
9
[Cytokines in bone diseases. Anti-cytokine therapies for bone and joint diseases].[骨疾病中的细胞因子。用于骨与关节疾病的抗细胞因子疗法]
Clin Calcium. 2010 Oct;20(10):1545-52.
10
Early rheumatoid arthritis.早期类风湿关节炎
Curr Opin Rheumatol. 2007 May;19(3):278-83. doi: 10.1097/BOR.0b013e32805e87bf.